Because STAT3 has been implicated in malignant transformation and tumor cell survival,[29, 43–45] and in interacting with Src-dependent signaling, we examined whether STAT3 knockdown would enhance the effects of Src inhibition in glioma cell lines. The gene discussed is STAT3; the disease is central nervous system cancer.